AXSOME THERAPEUTICS INC (AXSM)
NASDAQ • Healthcare
Last close at August 11, 2026 at 20:00 UTC
Fundamentals Charts
About AXSOME THERAPEUTICS INC
Axsome Therapeutics, Inc. is a Biotechnology company listed on the NASDAQ under AXSM that develops and commercializes central nervous system therapies in the United States. The company generated $638.5 million in revenue in FY2025 and focuses on prescription medicines and late-stage development candidates for neurologic and psychiatric conditions.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
AXSOME THERAPEUTICS INC's Technical Indicators Summary
AXSM exhibits a cautious sell profile as price hovers near 218 and close to its classic pivot, but short- and medium-term averages are uneven while the long-term trend remains constructive. Momentum and MACD readings are negative, pointing to selling pressure, and ADX around the low 20s suggests only modest trend strength. Volume measures show net buying, which tempers the downside, and volatility is moderate with ATR near 4%. Technical takeaway: the overall stance is sell, driven by weakening momentum against a mixed moving-average backdrop.
| Indicator | Value |
|---|---|
RSI (14) | 43.73 |
Stochastic %K (14, 3, 3) | 29.46 |
CCI (20) | -61.77 |
WPR (14) | -70.71 |
Momentum (10) | -9.18 |
MFI | 32.58 |
MACD Level (12, 26) | -6.00 |
Bollinger Bands | $202.79 - $248.63 |
ATR (14) | $8.99 (4.12%) |
ADX (14) | 21.28 |
OBV | 19,301,902 |
Classic Pivot Point | $218.06 |
Fibonacci Pivot Point | $218.06 |
Simple Moving Averages | $188.65 - $235.54(5 indicators) |
Exponential Moving Averages | $189.37 - $227.05(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
AXSM eased off and hovers -0.91% below yesterday’s close (215.77). A flat sector move (0.25%) keeps the macro backdrop muted for AXSM. UBS lifts AXSM price target to $280 from $259 and keeps Buy on Axsome.
Trading Volume
Below 10d avg (790.3K)
653K
vs S&P 500 Today
Underperforming Market
-1.16%
52-Week Position
Upper range
70.3%
Updated: August 12, 2026 at 17:29 UTC